Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. (DBTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DBTX · as of Jun 8, 2026
Key Statistics
Explore Decibel Therapeutics, Inc. Data
dbtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
Competitors & Peers
dbtx competitorsDBTX
ATYR
GRAY
JNCE
KNTE
NGMStock Performance
Full HistoryAbout Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. (DBTX) is a clinical-stage biotechnology firm dedicated to pioneering innovative therapies for a range of hearing and balance impairments. Their research and development eff…
what is decibel therapeutics, inc. · dbtx stock overview · decibel therapeutics, inc. company profile · who is decibel therapeutics, inc. ceo · dbtx NASDAQ · decibel therapeutics, inc. headquarters · decibel therapeutics, inc. business segments
About Stock Overview & Key Data
Decibel Therapeutics, Inc. (DBTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 12, 2021. As of the latest trading session, DBTX stock price is $4.91, with a market capitalization of $123.4M. The stock has returned +22.14% over the past 12 months and +136.63% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Decibel Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Decibel Therapeutics, Inc. reported revenue of — and net income of -$63.0M. For detailed data — including Decibel Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Decibel Therapeutics, Inc. (DBTX) stock price is $4.91. The stock is traded on NASDAQ under the ticker symbol DBTX. The 52-week range is $1.61 – $5.40.